中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Preparation of Ca-Alginate Microparticles and Its Application for Phenylketonuria Oral Therapy

文献类型:期刊论文

作者Zhang, Yueling1; Jia, Xingyuan2,3,4; Wang, Lianyan1; Liu, Jingzhong4; Ma, Guanghui1
刊名INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH
出版日期2011-04-06
卷号50期号:7页码:4106-4112
关键词PHENYLALANINE AMMONIA-LYASE ELECTROSTATIC DROPLET GENERATION DRUG-DELIVERY CHITOSAN MICROSPHERES METABOLISM ADULTS ACID
ISSN号0888-5885
通讯作者Wang, LY
英文摘要Lactococcus lactis-expressing phenylalanine ammonia-lyase (LLEP) has been used to treat one of the classic genetic diseases, phenylketonuria (PKU). However, the action of stomach fluid and short residence time of LLEP at the site of absorption become the "neck" for the oral administration of LLEP. To solve these problems, pH-sensitive Ca-alginate microparticles designed as an oral administration carrier were prepared by a spray-solidification method in this study. The spray conditions influenced the size of the Ca-alginate micropartides; thus, conditions were optimized to obtain microparticles with smaller particle size for oral administration to mice. Subsequently, LLEP was encapsulated into Ca-alginate microparticles and the activity retention of LLEP released from the micropartides was examined after the microparticles passed through simulated gastric fluid. The results showed that LLEP could be well protected against simulated gastric fluid and that the final activity retention was up to 92.9%. The effects of alginate concentration on the release profile in vitro and the encapsulation efficiency (EE) were studied, and the results revealed that the microparticles possessed the highest EE and a reasonable release rate when the alginate concentration was 1.0 wt %. This alginate concentration, combined with optimized spray conditions, was used to prepare LLEP-encapsulated microparticles, and they were administered orally to mice with phenylketonuria (PKU). Compared with the groups given blank microparticles and non-encapsulated LLEP, the increase of the blood phenylalanine (Phe) level was significantly slowed after a 7 day treatment with LLEP-encapsulated microparticles. Consequently, the Ca-alginate microparticle developed by the spray-solidification method is a promising carrier of LLEP for oral administration.
WOS标题词Science & Technology ; Technology
类目[WOS]Engineering, Chemical
研究领域[WOS]Engineering
关键词[WOS]PHENYLALANINE AMMONIA-LYASE ; ELECTROSTATIC DROPLET GENERATION ; DRUG-DELIVERY ; CHITOSAN ; MICROSPHERES ; METABOLISM ; ADULTS ; ACID
收录类别SCI
语种英语
WOS记录号WOS:000288833700050
公开日期2013-11-06
版本出版稿
源URL[http://ir.ipe.ac.cn/handle/122111/5050]  
专题过程工程研究所_生化工程国家重点实验室
作者单位1.Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing 100190, Peoples R China
2.Chinese Acad Med Sci, Inst Basic Med Sci, Beijing 100005, Peoples R China
3.Peking Union Med Coll, Beijing 100005, Peoples R China
4.Capital Med Univ, Beijing Chaoyang Hosp, Beijing 100020, Peoples R China
推荐引用方式
GB/T 7714
Zhang, Yueling,Jia, Xingyuan,Wang, Lianyan,et al. Preparation of Ca-Alginate Microparticles and Its Application for Phenylketonuria Oral Therapy[J]. INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH,2011,50(7):4106-4112.
APA Zhang, Yueling,Jia, Xingyuan,Wang, Lianyan,Liu, Jingzhong,&Ma, Guanghui.(2011).Preparation of Ca-Alginate Microparticles and Its Application for Phenylketonuria Oral Therapy.INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH,50(7),4106-4112.
MLA Zhang, Yueling,et al."Preparation of Ca-Alginate Microparticles and Its Application for Phenylketonuria Oral Therapy".INDUSTRIAL & ENGINEERING CHEMISTRY RESEARCH 50.7(2011):4106-4112.

入库方式: OAI收割

来源:过程工程研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。